Cross-Border Health Insurance and Future of Medical Tourism
An exclusive, deep-dive interview with Laurent Pochat-Cottilloux, Global Head of Health Reinsurance Partnerships at AXA, uncovering the technical mechanisms between international insurers and sovereign provider networks.
By Laurent Pochat-Cottilloux
Global Head of Health Reinsurance Partnerships, AXA
Leading architect of international private medical insurance, managing cross-border underwriting, risk diversification, and global B2B provider networks.
Destination Health:
Could you tell us more about cross-border health insurance and how it fits into the current medical tourism market?
Laurent Pochat-Cottilloux:
Traditionally, health insurance companies have operated as purely local entities, covering medical risks strictly within national boundaries. However, as medical costs fluctuate globally and specialized clinical excellence clusters form across regions, we observe structural demand for international mobility. Cross-border insurance acts as the necessary financial engine. It transitions the insurer from a reactive payer into an active operational partner that secures pre-funding pipelines and balances clinical access with regional cost containment.
"The evolution of true corporate health travel relies entirely on standardizing pre-funding networks and mitigating the systemic risk of post-operative complications."
Destination Health:
What are the primary operational challenges when underwriting international patient populations, particularly regarding complications?
Laurent Pochat-Cottilloux:
The single most severe friction point in health travel economics is post-operative complication management. When a corporate patient crosses a border for a complex procedure and returns home, any secondary clinical emergency creates complex coverage gaps. Standard domestic policies often refuse to pay for complications arising from unaccredited elective surgeries performed abroad. Reinsurers solve this by building specialized global complication insurance portfolios. These safeguard both the B2B provider network and the corporate buyer, ensuring seamless continuity of care without inflating regional medical liabilities.
Destination Health:
How should healthcare destinations adjust their corporate strategy to partner with global insurance giants like AXA?
Laurent Pochat-Cottilloux:
Hospitals aiming for true internationalization must look beyond transient, direct-to-consumer digital clutter. Corporate volume requires structural alignment with international payers. Insurers demand data-driven transparency: JCI or independent international accreditation, predictable package pricing, and verifiable clinical outcome tracking. When a medical destination aligns its infrastructure with underwriting standards, it transitions into a permanent node within a global insurance provider network, unlocking a sustainable pipeline of pre-funded international patients.